Clinical Trials in Los Angeles

Showing 13681-13700 of 16,901 trials

A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years

NCT02212106

This is a study to assess the safety of a bioCSL split virion, inactivated Trivalent Influenza Virus vaccine containing the 2014/2015 Northern Hemisphere strains of vaccine in children aged 5 years to less than 9 years. Comparison will be made to a licensed Quadrivalent Influenza Virus vaccine that complies with the FDA recommendations for the 2014/2015 influenza season in the US.

Influenza, Human

Seqirus402 participantsStarted Sep 2014

Los Angeles, California, United States • Boise, Idaho, United States • St Louis, Missouri, United States +8 more locations

COMPLETEDPhase 3< 1 mile

Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients

NCT01262456

The purpose of this trial was to confirm/establish long-term safety and efficacy of desmopressin orally disintegrating tablets at dose levels of 50 μg and 75 μg and to further evaluate the safety of an efficacious higher dose level of 100 μg in males with nocturia.

Nocturia

Ferring Pharmaceuticals395 participantsStarted Feb 2011

Anniston, Alabama, United States • Huntsville, Alabama, United States • Scottsdale, Arizona, United States +53 more locations

A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years

Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients

Find Trials by Condition in Los Angeles

Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age

Pioglitazone in Early Parkinson's Disease

Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

PoC in Rheumatoid Arthritis With Methotrexate

Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients

A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease

Safety Study of BMS-770767 in Subjects With Type 2 Diabetes

Self Selection Trial of Naproxen Sodium

Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C

Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer

Gabapentin For the Control of Hot Flashes in Women With Breast Cancer

Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults

Brain Metastases In ErbB2-Positive Breast Cancer

Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer

Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Study to Examine the Effect of Betahistine on Body Weight Gain Due to Olanzapine Treatment